Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Streptomyces griseus (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human NADH-ubiquinone oxidoreductase 30 kDa (NDUFS3) and Streptomyces griseus co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Proteobacteria |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human NADH-ubiquinone oxidoreductase 30 kDa (NDUFS3) and Escherichia coli co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human NADH-ubiquinone oxidoreductase 30 kDa (NDUFS3) and Klebsiella pneumoniae co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Raoultella planticola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human NADH-ubiquinone oxidoreductase 30 kDa (NDUFS3) and Raoultella planticola co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
|
|
|
|
|
|